CDB-2914 for Abnormal Uterine Bleeding in Premenopausal Women
NCT01493791
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
WITHDRAWN
Status
NIH
Sponsor class
Conditions
Urogenital Abnormalities
Interventions
DRUG:
CDB-2914
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)